Echographic Measurement of Skin Thickness

Sponsor
Novosanis NV (Industry)
Overall Status
Completed
CT.gov ID
NCT02363465
Collaborator
(none)
100
1
5
20.2

Study Details

Study Description

Brief Summary

To optimize a medical device for intradermal injection, knowledge concerning the thickness of epidermis and dermis at the proximal forearm is required. Since scientific knowledge is lacking, the investigators will examine the skin thickness (epidermis and dermis) of adults using imaging technology (High Frequency Ultrasound). The investigators hypothesize that they are able to correlate the thickness of the (epi)dermis to a specific combination of parameters age, gender, and BMI.

Based on these results, the investigators can define which needle type and length is needed to correctly perform injections into the dermal layer.

Condition or Disease Intervention/Treatment Phase
  • Other: Echographic measurement of skin thickness

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Echographic Measurement of Skin Thickness at the Deltoid and Proximal Forearm in Adults
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Participants aged 18-30 years

Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 18-30 years. aimed number: 12 male & 12 female maximum number: 15 male & 15 female

Other: Echographic measurement of skin thickness
(Epi)Dermal thickness at the proximal forearm and the deltoid region will be measured using imaging technology, more specifically high-frequency ultrasound (20-40 MHz) in B-mode (VEVO 2100®, Visual Sonics). This non-invasive measuring technique has already been proven to be accurate. The echographic measurement will be performed on the left and right deltoid region and on two sides of the proximal forearm. Both the dorsal part and the volar/palmar part of the proximal forearm will be investigated. Ultrasound will be executed using gel (Aquasonic®) to optimize imaging.

Participants aged 31-40 years

Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 31-40 years. aimed number: 12 male & 12 female maximum number: 15 male & 15 female

Other: Echographic measurement of skin thickness
(Epi)Dermal thickness at the proximal forearm and the deltoid region will be measured using imaging technology, more specifically high-frequency ultrasound (20-40 MHz) in B-mode (VEVO 2100®, Visual Sonics). This non-invasive measuring technique has already been proven to be accurate. The echographic measurement will be performed on the left and right deltoid region and on two sides of the proximal forearm. Both the dorsal part and the volar/palmar part of the proximal forearm will be investigated. Ultrasound will be executed using gel (Aquasonic®) to optimize imaging.

Participants aged 41-50 years

Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 41-50 years. aimed number: 12 male & 12 female maximum number: 15 male & 15 female

Other: Echographic measurement of skin thickness
(Epi)Dermal thickness at the proximal forearm and the deltoid region will be measured using imaging technology, more specifically high-frequency ultrasound (20-40 MHz) in B-mode (VEVO 2100®, Visual Sonics). This non-invasive measuring technique has already been proven to be accurate. The echographic measurement will be performed on the left and right deltoid region and on two sides of the proximal forearm. Both the dorsal part and the volar/palmar part of the proximal forearm will be investigated. Ultrasound will be executed using gel (Aquasonic®) to optimize imaging.

Participants aged 51-65 years

Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 51-65 years. aimed number: 12 male & 12 female maximum number: 15 male & 15 female

Other: Echographic measurement of skin thickness
(Epi)Dermal thickness at the proximal forearm and the deltoid region will be measured using imaging technology, more specifically high-frequency ultrasound (20-40 MHz) in B-mode (VEVO 2100®, Visual Sonics). This non-invasive measuring technique has already been proven to be accurate. The echographic measurement will be performed on the left and right deltoid region and on two sides of the proximal forearm. Both the dorsal part and the volar/palmar part of the proximal forearm will be investigated. Ultrasound will be executed using gel (Aquasonic®) to optimize imaging.

Outcome Measures

Primary Outcome Measures

  1. skin thickness (in milimeters) of the proximal forearm dorsal (both left and right) [10 minutes]

  2. skin thickness (in milimeters) of the proximal forearm ventral (both left and right) [10 minutes]

  3. skin thickness (in milimeters) of the deltoid region (both left and right) [10 minutes]

Secondary Outcome Measures

  1. Body Mass Index [at the moment of entering the study]

  2. Age [at the moment of entering the study]

  3. sex [at the moment of entering the study]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy adults

  • Age: 18-65 years

  • Dutch-speaking

  • Caucasian

Exclusion Criteria:
  • Pregnancy or lactating

  • Using ointment, crème, or gels based on corticoids

  • Suffering from skin diseases (psoriasis, burning wounds)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Pharmaceutical Sciences; Laboratory of Physiopharmacology; University of Antwerp; Campus Drie Eiken Wilrijk Antwerp Belgium 2610

Sponsors and Collaborators

  • Novosanis NV

Investigators

  • Principal Investigator: Vanessa Vankerckhoven, PhD, CEO

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Novosanis NV
ClinicalTrials.gov Identifier:
NCT02363465
Other Study ID Numbers:
  • 300201523257
First Posted:
Feb 16, 2015
Last Update Posted:
Oct 6, 2015
Last Verified:
Oct 1, 2015
Keywords provided by Novosanis NV

Study Results

No Results Posted as of Oct 6, 2015